Equifax Inc (EFX) stock analysis
Close on Nov 11, 2026Market cap $22.05BP/E 30.4Yield 1.00%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid18 of 30 checks passed
Equifax passes 18 of the 30 checks behind our score. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 3/6
- Growth
- 2/6
- Past performance
- 4/6
- Financial health
- 5/6
- Dividend
- 4/6
What stands out
Trading below fair value
The share price of $188.41 is below our fair value estimate of $232.50.
Return on equity over 15%
Return on equity was 15.8% over the last twelve months and averaged 16.1% over five years.
Earnings grew over 5 years
Net income grew 4.9% a year on average over the last five fiscal years.
Earnings growth accelerating
Net income grew 12.8% over the last twelve months, against a 5-year average of 4.9% a year.
What to watch
Margin of safety under 20%
The price is 19.0% below fair value, less than the 20% cushion we look for.
Return on capital under 10%
Return on invested capital was 9.5%, below the 10% that usually covers the cost of capital.
High debt
Debt is 116% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew 5.8% a year over the last three fiscal years, short of the 10% we look for.
Valuation3/6
P/E below its 5-year median
Equifax's P/E of 30.4 is below its own 5-year median of 43.0.
P/E above the industry
Equifax's P/E of 30.4 is above the Business Services median of 26.9.
EV/EBITDA below its 5-year median
Equifax's EV/EBITDA of 13.6 is below its 5-year median of 19.8.
P/B above the industry
Equifax's price-to-book of 4.93 is above the Business Services median of 2.98.
Trading below fair value
The share price of $188.41 is below our fair value estimate of $232.50.
Margin of safety under 20%
The price is 19.0% below fair value, less than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew 5.8% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -2.0% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 12.8% over the last twelve months, against a 5-year average of 4.9% a year.
Growing faster than the industry
Revenue grew 10.9% over the last twelve months; the Business Services median is 9.1%.
Guidance lowered
Equifax lowered its Q3 2026 Organic Local Currency Growth (1) outlook on Jul 21, 2026.
Gross margin slipping
Gross margin was 55.2% over the last twelve months, against 56.3% a year earlier.
Past performance4/6
Return on equity over 15%
Return on equity was 15.8% over the last twelve months and averaged 16.1% over five years.
Return on capital under 10%
Return on invested capital was 9.5%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Equifax's return on equity of 15.8% is above the Business Services median of 1.4%.
Earnings grew over 5 years
Net income grew 4.9% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 11.3% over the last twelve months, against a 5-year average of 12.1%.
Net margin above the industry
Equifax's net margin of 11.3% is above the Business Services median of -1.7%.
Financial health5/6
High debt
Debt is 116% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 138% five years ago to 116%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 31.0% of total debt.
Interest well covered
Operating income covers interest expense 5.4 times.
Short-term assets cover short-term debts
Current assets are 1.09 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.51; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Equifax paid dividends worth 1.2% of the share price over the last twelve months.
Yield below Treasuries
The 1.2% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Equifax yields 1.2%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 35.0% of net income.
Covered by free cash flow
Dividends take 23.6% of free cash flow.
Fair value
How we estimate itOur estimate per share
$232.50
The share price is 19% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 35.0× | 43.0× | 26.9× | $216.59 | 47% |
| EV/EBITDA | 18.1× | 19.8× | 16.4× | $266.15 | 41% |
| P/B | 4.7× | 6.3× | 3.0× | $178.41 | 12% |
| Earnings powerleft out, too far from the others | 11.1% cost of equity | – | – | $63.27 | – |
| Fair value | $232.50 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 43.0
- Business Services median 26.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $333.87M
- Value traded per 1% price move
- $156.16M
Downside
Medium risk
- Typical loss in a bad month
- 22.7%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- -0.34
- Beta to the S&P 500 (5Y)
- 1.24
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.9% | +5.8% | +8.0% | +8.6% | |
| Gross profit | +8.4% | +5.2% | +7.5% | +6.8% | |
| Operating income | +5.1% | +1.2% | +10.1% | +4.7% | |
| Net income | +9.3% | -1.7% | +4.9% | +4.4% | |
| EPS, diluted | +9.9% | -2.0% | +4.6% | +4.1% | |
| Free cash flow | +39.5% | +104.5% | +16.7% | +6.2% | |
| Dividend per share | +21.2% | +6.6% | +3.9% | +5.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 19.7% | 18.1% | 14.0% | |
| Return on assets | 8.8% | 5.9% | 5.6% | |
| Current ratio | 0.53 | 1.00 | 0.60 | |
| Debt to equity | 1.00 | 1.38 | 1.11 | |
| Net debt to EBITDA | 2.32× | 2.50× | 2.70× | |
| Interest coverage | 9.0× | 4.8× | 5.2× | |
| Capex to revenue | 5.5% | 10.2% | 7.9% | |
| Diluted shares | 121M | 123M | 124M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Equifax generated $6.15B from operations and spent $4.68B on capital expenditure, dividends and share buybacks. 57% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 10.9% | 0.51× | 2.51× | 14.0% |
| FY2024 | 10.6% | 0.47× | 2.58× | 12.9% |
| FY2023 | 10.4% | 0.44× | 2.81× | 12.8% |
| FY2022 | 13.6% | 0.45× | 3.00× | 18.5% |
| FY2021 | 15.1% | 0.48× | 3.06× | 22.0% |
| FY2020 | 12.6% | 0.47× | 3.05× | 18.1% |
| FY2019 | -11.0% | 0.47× | 2.65× | -13.5% |
| FY2018 | 9.1% | 0.47× | 2.29× | 9.9% |
| FY2017 | 17.5% | 0.48× | 2.38× | 20.1% |
| FY2016 | 15.5% | 0.56× | 2.24× | 19.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$660.30M
- Cash generatingOperating cash flow above zero$1.62B
- Return on assets improvedROA up on the prior year4.9% → 5.6%
- Earnings backed by cashOperating cash flow above net income$1.62B vs $660.30M
- Less leverageLong-term debt to assets fell36.8% → 34.2%
- Better liquidityCurrent ratio rose0.75 → 0.60
- No dilutionShare count did not rise125M → 124M
- Gross margin improvedGross margin up on the prior year55.67% → 56.45%
- More efficientAsset turnover rose0.46 → 0.52
See a number that looks wrong?